Fidelity Disruptive Medicine ETF Rating $30.50 -0.54 (-1.74%) Closing price 03:46 PM EasternExtended Trading$30.53 +0.03 (+0.10%) As of 05:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatings Fidelity Disruptive Medicine ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FMED Aggregate RatingModerate Buy 2.72Holdings in FMED have an aggregate rating of Moderate Buy based on 455 analyst ratings issued in the past year covering 23 companies (59.6% of the portfolio).FMED Aggregate Price Target$30.50High Prediction$30.50Average Prediction$30.50Low Prediction$30.50Holdings in FMED have an aggregate price target of $30.50 and a range of $30.50 to $30.50 covering 23 companies (59.6% of the portfolio).FMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Fidelity Disruptive Medicine ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 FMED Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings5.14%TXG10x Genomics$71.79-4.5%Hold$68.00 -5.3%181.9128 of 5 starsAnalyst Forecast4.40%NTRANatera$395.65-0.5%Moderate Buy$363.93 -8.0%231.8866 of 5 starsAnalyst Forecast4.13%TMOThermo Fisher Scientific$663.46+0.2%Moderate Buy$642.33 -3.2%254.1094 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision3.88%DHRDanaher$223.30+0.9%Moderate Buy$235.41 5.4%233.9007 of 5 starsPositive NewsAnalyst Upgrade3.71%ILMNIllumina$271.17-2.0%Hold$225.94 -16.7%182.9101 of 5 starsAnalyst Upgrade2.79%LFSTLifeStance Health Group$12.32-1.3%Moderate Buy$13.13 6.5%113.5009 of 5 stars2.69%MRNAModerna$216.25+1.2%Hold$100.60 -53.5%261.7556 of 5 starsTrending NewsGap Down2.68%RVMDRevolution Medicines$188.44-2.8%Moderate Buy$234.76 24.6%242.8799 of 5 stars2.59%ARGXargenex$802.64-1.2%Moderate Buy$1,155.05 43.9%304.646 of 5 starsAnalyst Forecast2.28%ALNYAlnylam Pharmaceuticals$223.82-1.4%Moderate Buy$366.65 63.8%254.1605 of 5 stars2.25%ISRGIntuitive Surgical$422.06-1.3%Moderate Buy$498.83 18.2%314.2795 of 5 starsTrending NewsUpcoming EarningsAnalyst ForecastAnalyst Revision2.23%WSTWest Pharmaceutical Services$371.66+1.1%Moderate Buy$391.17 5.2%143.6975 of 5 starsAnalyst Forecast2.20%HTFLHeartflow$50.32-0.5%Moderate Buy$46.25 -8.1%121.3127 of 5 stars2.18%PCVXVaxcyte$66.80-5.4%Moderate Buy$110.50 65.4%92.8197 of 5 starsAnalyst Forecast2.13%GHGuardant Health$162.09-0.4%Moderate Buy$190.00 17.2%252.3709 of 5 starsAnalyst Forecast2.07%COGTCogent Biosciences$28.09-5.7%Moderate Buy$51.56 83.5%122.8363 of 5 starsPositive News2.00%KNSAKiniksa Pharmaceuticals International$78.53-0.9%Moderate Buy$93.14 18.6%94.1549 of 5 stars1.87%KYMRKymera Therapeutics$106.68-4.8%Moderate Buy$134.68 26.2%272.6881 of 5 stars1.74%ASNDAscendis Pharma A/S$223.21-1.7%Buy$313.21 40.3%204.8066 of 5 starsAnalyst Upgrade1.74%VEEVVeeva Systems$302.02+2.1%Moderate Buy$284.88 -5.7%282.8431 of 5 starsTrending NewsAnalyst Upgrade1.71%RGENRepligen$175.42+1.7%Moderate Buy$173.21 -1.3%182.223 of 5 starsPositive News1.62%ROIVRoivant Sciences$33.35-3.6%Moderate Buy$45.64 36.8%142.7333 of 5 starsAnalyst Downgrade1.57%TWSTTwist Bioscience$151.33-0.3%Hold$143.67 -5.1%131.9947 of 5 starsAnalyst ForecastInsider Trade This page (NASDAQ:FMED) was last updated on 10/13/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Fidelity Disruptive Medicine ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
